http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY#Head http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY#assertion http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY#provenance http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY#pubinfo http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY#assertion http://purl.obolibrary.org/obo/DOID_9253 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_9253 http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB08896 http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY#association http://www.w3.org/2000/01/rdf-schema#label stivarga is a kinase inhibitor indicated for the treatment of patients with 1 1 1 2 stivarga is indicated for the treatment of patients with metastatic colorectal cancer crc who have been previously treated with fluoropyrimidine oxaliplatin and irinotecan based chemotherapy an anti vegf therapy and if ras wild type an anti egfr therapy stivarga is indicated for the treatment of patients with locally advanced unresectable or metastatic gastrointestinal stromal tumor gist who have been previously treated with imatinib mesylate and sunitinib malate stivarga is indicated for the treatment of patients with hepatocellular carcinoma hcc who have been previously treated with sorafenib http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB08896 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY#provenance http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY#pubinfo http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY#sig http://purl.org/nanopub/x/hasSignature e8IYKCAPFzSbZkByn9TqSSmsX3mC+eLS1JbPT5wchH9wl6AnqmFlOpbUoicMm1uo4RHbfy9eqVCEuC9VPANAsLlOWE83UsdtTOWuoGeE+/jw4CTuDxkq12p/I7k8havuMWI4QEmE9UBp+811LTFTHZ0tIjFl8U2DSJk9uK2BOWA= http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY http://purl.org/dc/terms/created 2021-06-12T14:55:59.525+02:00 http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAbkpODkf020xyvZdFpUNPeUnSlMy6dZblJDo9kjepfOY https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs